Welcome to our dedicated page for Perimeter Medical Imaging Ai news (Ticker: PYNKF), a resource for investors and traders seeking the latest updates and insights on Perimeter Medical Imaging Ai stock.
Perimeter Medical Imaging AI Inc (PYNKF) delivers cutting-edge imaging solutions for cancer surgery, specializing in AI-enhanced optical coherence tomography (OCT) systems. This page provides official updates on regulatory milestones, clinical research, and technological advancements shaping surgical oncology.
Investors and medical professionals will discover timely updates about the company’s FDA-cleared S-Series OCT platform, B-Series AI integration progress, and strategic partnerships. Content includes earnings reports, trial outcomes, and educational initiatives demonstrating real-world clinical impact.
Key updates cover surgical margin visualization innovations, regulatory submissions, and peer-reviewed study results. All materials are sourced directly from company filings and verified medical publications to ensure accuracy.
Bookmark this page for consolidated access to Perimeter’s latest developments in AI-driven surgical imaging. Regularly updated to reflect new achievements in precision oncology and operational growth.
Perimeter Medical Imaging AI, Inc. (TSXV: PINK, OTC: PYNKF) announced its participation at the 24th Annual Meeting of the American Society of Breast Surgeons (ASBrS) from April 26-30, 2023, in Boston, MA. The company will host an educational symposium titled "ACT IN THE MOMENT: OCT adds real-time clarity on margin status," featuring prominent breast surgeons who will share their experiences utilizing the Perimeter S-Series Optical Coherence Tomography (OCT) technology. This device provides real-time imaging to assist surgeons during procedures. Perimeter will also offer live demonstrations at Booth #923, showcasing the OCT system's capabilities in visualizing tissue margins at a cellular level. The event underscores Perimeter's commitment to advancing breast cancer surgery technology.
Perimeter Medical Imaging AI, Inc. (OTC: PYNKF) announced the first commercial placement of its Perimeter S-Series OCT system in Utah on April 25, 2023. This FDA-cleared imaging tool, launched in 2021, enhances cancer surgery with real-time, cross-sectional visualization of excised tissues. Dr. Jennifer J. Tittensor, a breast surgeon, will utilize the system to improve margin assessments during surgeries. Perimeter's CEO, Jeremy Sobotta, noted growing interest from surgeons, indicating a positive sales momentum. The company is also advancing its next-generation Perimeter B-Series OCT with ImgAssist AI, supported by a grant of up to $7.4 million from the Cancer Prevention and Research Institute of Texas, highlighting its commitment to innovation in oncological surgery.
FAQ
What is the current stock price of Perimeter Medical Imaging Ai (PYNKF)?
What is the market cap of Perimeter Medical Imaging Ai (PYNKF)?
